Phase 3 Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 35 years old (male or female)
- You have been diagnosed with schizophreniform disorder, schizophrenia, schizoaffective disorder, or unspecified psychosis
- You have been receiving treatment for psychosis for less than five years
- Your symptoms are below a certain level of severity, as measured by a standard rating scale called the PANSS (confirm with trial site)
- You are able to understand and agree to take part in the study on your own
Who may not be able to join:
- You have been diagnosed with a substance use disorder (such as alcohol or drug addiction) in the past 6 months — note that tobacco use and mild-to-moderate cannabis use do not disqualify you
- You have an active medical condition that currently requires changes to your treatment, such as an autoimmune disease, active infection, HIV/AIDS, cancer, kidney failure, liver problems, heart disease, or an abnormal thyroid — however, stable, well-managed chronic conditions are generally acceptable
- You have epilepsy or another condition that causes seizures
- You have an intellectual disability or a history of significantly low IQ
- You are under legal guardianship
- You do not speak English, as the study tools have only been developed and tested in English
- You have a known allergy to MitoQ (the supplement being studied in this trial)
- You have taken antioxidant supplements — such as fish oil, Vitamin E, Vitamin C, multivitamins, or NAC — within the last 14 days (confirm with trial site, as stopping these may make you eligible)
- You are under 18, pregnant, planning to become pregnant during the study, or currently breastfeeding
- You are a woman who could become pregnant and are not willing or able to use a reliable form of contraception throughout the study (confirm with trial site for what counts as acceptable contraception)
- You are a member of the study staff, a family member of study staff, or someone who depends on a staff member
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dost Ongur, MD, PhD, Mclean Hospital
Phone: 6178553922
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from baseline in the MATRICS Consensus Cognitive Battery (MCCB) composite score at week 12
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.